The disruption of the epigenetic mechanisms of gene expression regulation due to the emergence of pathogenic variants in genes-encoding elements of epigenetic machinery leads to the development of chromatinopathies. This group of hereditary diseases includes 179 syndromes, some of which present with overlapping phenotypes. Despite the variety of approaches to molecular diagnostics of chromatinopathies, it is not always possible to establish the molecular diagnosis by traditional methods; thus, the issue of optimizing diagnostic algorithms remains relevant. One of the most rapidly expanding areas of post-genomic molecular diagnostics is episignature detection, which relies on genome-wide DNA methylation analysis. This article aims to represent an original approach to indirect diagnostics of chromatinopathies on the example of Rubinstein–Taybi syndrome 1, which is based on the analysis of the methylation level of a limited set of loci designed to reproduce its classic episignature. In the current study, we apply two methods of targeted quantitative analysis of DNA methylation, which are relatively accessible and can be integrated into diagnostic practice. We demonstrate that Rubinstein–Taybi syndrome 1 episignature may be successfully reduced to a single locus of human genome, and that quantitative bisulfite DNA methylation analysis at this locus allows accurate identification of the Rubinstein–Taybi syndrome 1 patients.
There are several forms of monoallelic expression, in which the 50:50 ratio in the expression activity of each of the two copies of the gene is disrupted. This review focuses on the phenomenon of random autosomal monoallelic expression (aRME), a process in which only one of the two alleles is transcribed in a single cell, and the allele choice is not determined by the parental origin. One of the central problems in studying this phenomenon is the differentiation of the two forms of aRME: clonal, in which the expression pattern is mitotically inherited, and stochastic, when the allele choice can change over time due to transcriptional bursting. Distinguishing these events is methodologically challenging: divergent experimental approaches and the lack of standardized detection criteria have produced strikingly contradictory estimates of aRME prevalence. Furthermore, single-cell transcriptomic approaches are particularly susceptible to technical artefacts that can generate false-positive monoallelic calls, complicating the distinction between heritable and transient states. In this review, we critically evaluate the evidence for clonal and stochastic aRME, examine the epigenetic mechanisms proposed to maintain monoallelic expression, and discuss its clinical significance, focusing on the role of monoallelic expression in the penetrance of autosomal dominant diseases (including congenital immune disorders and cardiomyopathy), neurodevelopmental disorders, and cancer progression.